Hui Ou Yang
Oprichter bij MingMed Biotechnology Co., Ltd.
Profiel
Hui Ou Yang is the founder and Chief Technology Officer of MingMed Biotechnology Co., Ltd., a company founded in 2019.
Dr. Ou Yang holds an MBA from the University of California, Los Angeles, an undergraduate and graduate degree from Peking University Health Science Center, and a doctorate from the University of North Carolina at Chapel Hill.
Actieve functies van Hui Ou Yang
| Bedrijven | Functie | Begin |
|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Oprichter | 25-11-2019 |
Opleiding van Hui Ou Yang
| Peking University Health Science Center | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
| University of California, Los Angeles | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
